Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
Sponsor: Nanoscope Therapeutics Inc.
Summary
The current study is a non-interventional long-term safety follow-up of the subjects who completed STARLIGHT, in accordance with FDA guidance on recipients of human gene therapy products.
Official title: Long Term Follow-up for Participants Who Previously Received a Single Intravitreal Injection of MCO-010 Optogenetic Therapy in the STARLIGHT Study
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
6
Start Date
2023-10-19
Completion Date
2027-07
Last Updated
2025-03-24
Healthy Volunteers
No
Conditions
Interventions
Gene Therapy Product-MCO-010
The MCO-010 is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette
Locations (2)
Nanocope Clnical Site
Miami, Florida, United States
Nanoscope Clinical Site
McAllen, Texas, United States